Xenon Pharmaceuticals Inc. (XENE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | N/A |
| Enterprise value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.79 |
| 52-week change 3 | N/A |
| S&P500 52-week change 3 | N/A |
| 52-week high 3 | 36.42 |
| 52-week low 3 | 14.65 |
| 50-day moving average 3 | 30.50 |
| 200-day moving average 3 | 27.82 |
Share statistics
| Avg vol (3-month) 3 | 466.12k |
| Avg vol (10-day) 3 | 482.71k |
| Shares outstanding 5 | 51.59M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 39.91M |
| % held by insiders 1 | 2.16% |
| % held by institutions 1 | 93.50% |
| Shares short (28 Apr 2022) 4 | 2.01M |
| Short ratio (28 Apr 2022) 4 | 4.85 |
| Short % of float (28 Apr 2022) 4 | 3.84% |
| Short % of shares outstanding (28 Apr 2022) 4 | 3.79% |
| Shares short (prior month 30 Mar 2022) 4 | 2.17M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Dec 2021 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -428.45% |
Management effectiveness
| Return on assets (ttm) | -12.97% |
| Return on equity (ttm) | -21.87% |
Income statement
| Revenue (ttm) | 18.44M |
| Revenue per share (ttm) | 0.35 |
| Quarterly revenue growth (yoy) | -27.40% |
| Gross profit (ttm) | -57.03M |
| EBITDA | -78.09M |
| Net income avi to common (ttm) | -78.88M |
| Diluted EPS (ttm) | -1.55 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 551.77M |
| Total cash per share (mrq) | 10.42 |
| Total debt (mrq) | 8.26M |
| Total debt/equity (mrq) | 1.50 |
| Current ratio (mrq) | 39.03 |
| Book value per share (mrq) | 5.87 |
Cash flow statement
| Operating cash flow (ttm) | -69.5M |
| Levered free cash flow (ttm) | -43.76M |
© 2022 Yahoo. All rights reserved.
